Citadel Advisors’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $30.7M | Sell |
2,422,741
-11,969
| -0.5% | -$136K | 0.02% | 1843 |
|
|
2025
Q4 | $19.9M | Buy |
2,434,710
+1,236,706
| +103% | +$14.2M | 0.01% | 2349 |
|
|
2025
Q3 | $14.4M | Sell |
1,198,004
-204,764
| -15% | -$2.15M | 0.01% | 2748 |
|
|
2025
Q2 | $14.2M | Buy |
1,402,768
+890,879
| +174% | +$5.98M | 0.01% | 2581 |
|
|
2025
Q1 | $2.86M | Buy |
511,889
+475,463
| +1,305% | +$4.16M | ﹤0.01% | 4855 |
|
|
2024
Q4 | $294K | Buy |
36,426
+30,659
| +532% | +$281K | ﹤0.01% | 9697 |
|
|
2024
Q3 | $59.1K | Buy |
+5,767
| New | +$57K | ﹤0.01% | 11727 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 15139 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 15311 |
|
|
2023
Q4 | – | Sell |
-145,007
| Closed | -$877K | – | 15022 |
|
|
2023
Q3 | $877K | Buy |
145,007
+66,732
| +85% | +$547K | ﹤0.01% | 6852 |
|
|
2023
Q2 | $607K | Sell |
78,275
-41,328
| -35% | -$235K | ﹤0.01% | 7508 |
|
|
2023
Q1 | $682K | Buy |
119,603
+40,970
| +52% | +$214K | ﹤0.01% | 7637 |
|
|
2022
Q4 | $463K | Buy |
78,633
+66,196
| +532% | +$223K | ﹤0.01% | 8401 |
|
|
2022
Q3 | $40K | Sell |
12,437
-187,950
| -94% | -$752K | ﹤0.01% | 11760 |
|
|
2022
Q2 | $898K | Sell |
200,387
-30,300
| -13% | -$121K | ﹤0.01% | 7266 |
|
|
2022
Q1 | $1.23M | Buy |
+230,687
| New | +$2.08M | ﹤0.01% | 7226 |
|
|
2021
Q4 | – | Sell |
-15,377
| Closed | -$322K | – | 14571 |
|
|
2021
Q3 | $322K | Sell |
15,377
-3,938
| -20% | -$79.8K | ﹤0.01% | 10903 |
|
|
2021
Q2 | $342K | Buy |
+19,315
| New | +$423K | ﹤0.01% | 10951 |
|
|
2021
Q1 | – | Sell |
-40,435
| Closed | -$1.37M | – | 13643 |
|
|
2020
Q4 | $1.37M | Sell |
40,435
-26,772
| -40% | -$768K | ﹤0.01% | 6126 |
|
|
2020
Q3 | $1.68M | Buy |
67,207
+60,376
| +884% | +$1.44M | ﹤0.01% | 5053 |
|
|
2020
Q2 | $230K | Buy |
+6,831
| New | +$218K | ﹤0.01% | 8329 |
|
Other funds holding ORIC
NI
EC
SOCM
P
VA
NMC